Evidence map›Paper›PMID 24048736›Full record

Trial reportGut2014

A novel urine peptide biomarker-based algorithm for the prognosis of necrotising enterocolitis in human infants.

Karl G Sylvester, Xuefeng B Ling, G Y Liu, Zachary J Kastenberg, Jun Ji, Zhongkai Hu, Sihua Peng, Ken Lau, Fizan Abdullah, Mary L Brandt and 6 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Gut, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. [Research progress in artificial intelligence for the diagnosis and management of diseases in preterm infants].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Review
  6. [Recent advances in artificial intelligence for auxiliary diagnosis and management of neonatal necrotizing enterocolitis].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Transforming neonatal care with artificial intelligence: challenges, ethical consideration, and opportunities.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Karl G SylvesterDivision of Pediatric Surgery, Lucile Packard Children's Hospital, Stanford, USA Department of Surgery, Stanford University School of Medicine, Stanford, USA.
Xuefeng B LingDepartment of Surgery, Stanford University School of Medicine, Stanford, USA.
G Y LiuDepartment of Surgery, Stanford University School of Medicine, Stanford, USA Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, USA.
Zachary J KastenbergDepartment of Surgery, Stanford University School of Medicine, Stanford, USA.
Jun JiDepartment of Surgery, Stanford University School of Medicine, Stanford, USA.
Zhongkai HuDepartment of Surgery, Stanford University School of Medicine, Stanford, USA.
Sihua PengDepartment of Surgery, Stanford University School of Medicine, Stanford, USA.
Ken LauDepartment of Surgery, Stanford University School of Medicine, Stanford, USA.
Fizan AbdullahDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, USA.
Mary L BrandtDepartment of Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, USA.
Richard A EhrenkranzDepartment of Pediatrics, Yale University School of Medicine, New Haven, USA.
Mary Catherine HarrisDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, USA.
Timothy C LeeDepartment of Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, USA.
Joyce SimpsonDepartment of Pediatrics, Yale University School of Medicine, New Haven, USA.
Corinna BowersDivision of Pediatric Surgery, Nationwide Children's Hospital, Columbus, USA Department of Surgery, Ohio State College of Medicine, Columbus, USA.
R Lawrence MossDivision of Pediatric Surgery, Nationwide Children's Hospital, Columbus, USA Department of Surgery, Ohio State College of Medicine, Columbus, USA.

Funding

Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1UL1RR025744 · NCRR · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2008 to 2011
$22.4M
Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1UL1TR000093 · NCATS · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2012 to 2013
$6.5M
Qualifying Studies of Biomarkers for Neonatal DiseaseU01FD004194 · FDA · STANFORD UNIVERSITY · PI SYLVESTER, KARL G · 2011 to 2013
$915k
FDA HHS U01 FD004194NCATS NIH HHS UL1 TR000093NCATS NIH HHS UL1 TR001070NCATS NIH HHS UL1 TR001085NCRR NIH HHS UL1 RR025744
6 · The paper itself

Abstract

objectiveNecrotising enterocolitis (NEC) is a major source of neonatal morbidity and mortality. The management of infants with NEC is currently complicated by our inability to accurately identify those at risk for progression of disease prior to the development of irreversible intestinal necrosis. We hypothesised that integrated analysis of clinical parameters in combination with urine peptide biomarkers would lead to improved prognostic accuracy in the NEC population.

designInfants under suspicion of having NEC (n=550) were prospectively enrolled from a consortium consisting of eight university-based paediatric teaching hospitals. Twenty-seven clinical parameters were used to construct a multivariate predictor of NEC progression. Liquid chromatography/mass spectrometry was used to profile the urine peptidomes from a subset of this population (n=65) to discover novel biomarkers of NEC progression. An ensemble model for the prediction of disease progression was then created using clinical and biomarker data.

resultsThe use of clinical parameters alone resulted in a receiver-operator characteristic curve with an area under the curve of 0.817 and left 40.1% of all patients in an 'indeterminate' risk group. Three validated urine peptide biomarkers (fibrinogen peptides: FGA1826, FGA1883 and FGA2659) produced a receiver-operator characteristic area under the curve of 0.856. The integration of clinical parameters with urine biomarkers in an ensemble model resulted in the correct prediction of NEC outcomes in all cases tested.

conclusionsEnsemble modelling combining clinical parameters with biomarker analysis dramatically improves our ability to identify the population at risk for developing progressive NEC.

Indexed as

AlgorithmsArea Under CurveBiomarkersEnterocolitis, NecrotizingFemaleFibrinogenHumansInfantMalePeptidesPrognosisProspective StudiesRisk AssessmentROC CurveBiomarkersFibrinogenPeptidesClinical Decision MakingInflammatory MediatorsPaediatric GastroenterologyPaediatric SurgeryPeptides

Identifiers

PMID24048736
PMCPMC4161026

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.